uridine diphosphate has been researched along with 3'-o-(4-benzoyl)benzoyladenosine 5'-triphosphate in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Boucsein, C; Färber, K; Hanisch, UK; Kettenmann, H; Pavlovic, S; Zacharias, R | 1 |
Adinolfi, E; Baricordi, OR; Chiozzi, P; Di Virgilio, F; Morelli, A; Rizzo, R; Solini, A | 1 |
2 other study(ies) available for uridine diphosphate and 3'-o-(4-benzoyl)benzoyladenosine 5'-triphosphate
Article | Year |
---|---|
Purinergic receptors on microglial cells: functional expression in acute brain slices and modulation of microglial activation in vitro.
Topics: Adenosine Triphosphate; Adenosine-5'-(N-ethylcarboxamide); Animals; Animals, Newborn; Brain; Calcium; Cell Survival; Cells, Cultured; Chloride Channels; Dose-Response Relationship, Drug; Drug Interactions; In Vitro Techniques; Lipopolysaccharides; Magnesium; Membrane Potentials; Mice; Mice, Inbred C57BL; Microglia; Neural Conduction; Nitric Oxide; Patch-Clamp Techniques; Potassium Channels; Receptors, Purinergic; Time Factors; Uridine Diphosphate; Uridine Triphosphate; Vasodilator Agents | 2003 |
Enhanced P2X7 activity in human fibroblasts from diabetic patients: a possible pathogenetic mechanism for vascular damage in diabetes.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Adenosine Diphosphate; Adenosine Triphosphate; Apoptosis; Apyrase; Autocrine Communication; Cell Shape; Cytidine Triphosphate; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Fibroblasts; Fibronectins; Gene Expression Regulation; Humans; Interleukin-6; Membrane Potentials; Paracrine Communication; Pyridoxal Phosphate; Receptors, Purinergic P2; Receptors, Purinergic P2X7; Uridine Diphosphate; Uridine Triphosphate | 2004 |